Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IDO inhibitors
IDO inhibitors
#ASCO18: Don’t write off IDO yet, says NewLink
Fierce Biotech
Mon, 06/4/18 - 10:19 pm
IDO inhibitors
NewLink Genetics
ASCO 2018
indoximod
IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down
Xconomy
Thu, 05/31/18 - 08:17 pm
ASCO
oncology
IDO inhibitors
Incyte
Incyte wipes out late-phase epacadostat program after pivotal failure of Keytruda combination
Fierce Biotech
Wed, 05/2/18 - 09:55 am
Incyte
epacadostat
Keytruda
IDO inhibitors
Incyte's Horrible News Derails a Promising Class of Cancer Drugs
Motley Fool
Fri, 04/6/18 - 07:43 pm
Incyte
Merck
epacadostat
IDO inhibitors
Roche
NewLink Genetics
5 Game-Changing Cancer Drug Innovations Being Developed Right Now
Motley Fool
Thu, 10/12/17 - 10:45 am
cancer
cancer immunotherapies
CAR-T
T-cell receptors
TCR therapeutics
IDO inhibitors
epigenetics
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
Tue, 05/30/17 - 11:48 am
ASCO
IDO inhibitors
CAR-T
PDL-1 inhibitors
Merck
Incyte
NewLink Genetics
Novartis
Juno Therapeutics
Bristol-Myers Squibb